ArticleBritish journal of cancer2026
Anti-PDGFRα autoantibody - a novel diagnostic and prognostic marker - may mediate non-small cell lung cancer progression via the PI3K/AKT/NF-κB signaling pathway.
Fengqi Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.